The Role of Quinolones in Staphylococcal InfectionFootnote

Presented at the Advisory Board Meeting «Le infezioni riemergenti: gli stafilococchi» February 1987, Monaco/Monte Carlo.

References

• Baba S. Clinical Evaluation of Ciprofloxacin in the Fields of Surgery, Obstetrics and Gynecology, Dermatology, Otolaryngology and Ophthalmology. Proceedings of the 14th International Congress of Chemotherapy, Kyoto 1985. In: J Ishigami (Hrsg.): Recent Advances in Chemotherapy 1985: 61–65.
   Google Scholar
• Fass RJ. Clinical Efficacy and Safety of Oral Ciprofloxacin. Proceedings of the 14th International Congress of Chemotherapy, Kyoto 1985. In: J Ishigami (Hrsg.): Recent Advances in Chemotherapy 1985: 1654–1655.
   Google Scholar
• Greenberg RN, Reilly P, Weinandt W, Kodesh F, Bollinger M. Ciprofloxacin Treatment of Infections Caused by Gram-negative Bacilli or Staphylococcus aureus. Proceedings of the 14th International Congress of Chemotherapy, Kyoto 1985. In: J Ishigami (Hrsg.): Recent Advances in Chemotherapy 1985: 1652–1653.
   Google Scholar
• Kobayashi H. Summary of Clinical Studies with Ciprofloxacin in Japan. Proceedings of the 14th International Congress of Chemotherapy, Kyoto 1985. In: J Ishigami (Hrsg.): Recent Advances in Chemotherapy 1985: 71–75.
   Google Scholar
• Scully BE, Neu HC. Therapy of serious infections with intravenous ciprofloxacin. Am J Med (in press)
   Google Scholar
• Dellamonica P, Bernard E, Giaume F, Etesse H, Garraffo R. Clinical assessment of oral ciprofloxacin in 22 patients with severe infection. 5th Mediterranean Congress of Chemotherapy, Cairo 1986: Abstract 024.
   Google Scholar
• Van De Heyning PH, Pattyn SR, Valcke HD. Ciprofloxacin in oral treatment of ear infections. Pharm Weekbl/Sci Ed), 1986; 8: 63–66.
   Google Scholar
• Boerema JBJ. New 4-Quinolones in the treatment of urinary tract infections. Pharm Weekbl (Sci Ed) 1986; 8: 46–51.
   Google Scholar
• Galante D, Esposito S, Barba D, Giusti G. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease. Chemioterapia, 1986; 5–5: 322–326.
   Google Scholar
• Lechi A, Arosio E, Montesi G, Pancera P, Fostini R, Franata G. Clinical Evaluation of Ofloxacin in Respiratory and Urinary Tract Infections. Proceedings of the 14th Interantional Congress of Chemotherapy, Kyoto 1985. In: J Ishigami (Hrsg.): Recent Advances in Chemotherapy 1985: 1803–1804.
   Google Scholar
• Naber KG, Bischoff W, Sörgel F, Gutzler F, BartosikWich B. In-Vitro Activity, Pharmacokinetics, Clinical Safety and Therapeutic Efficacy of Enoxacin in the Treatment of Patients with Urinary Tract Infections. Vortrag anlässlich des 9. International Congress of Infectious and Parasitic Diseases, München, 20–26 July 1986.
   Google Scholar
• Norrby SR. Principles for targeted antibiotic use in urinary tract and enteric infections: a review with special emphasis on norfloxacin. Scand J Infect Dis, 1986; Suppl 48: 7–19.
   Google Scholar
• Grassi GG, Grassi C. Treatment of respiratory tract infections: Italian experiences. Proceedings of the 14th International Congress of Chemotherapy, Kyoto 1985. In: J Ishigami (Hrsg.): Recent Advances in Chemotherapy: 1985: 992.
   Google Scholar
• Niki Y, Hino J, Matsushima T, Kawane H, Nakahama C, Watanabe M, Soejima R. Experimental and Clinical Studies on the Effect of Ofloxacin against Respiratory Tract Infections. Proceedings of the 14th International Congress of Chemotherapy, Kyoto 1985. In: J Ishigami (Hrsg.): Recent Advances in Chemotherapy 1985: 57–63.
   Google Scholar
• Desplaces N, Gutmann L, Acar JF. Treatment of Chronic Osteomyelitis Due to Staphylococcus spp. or Gramnegative Bacteria with a New Quinolone: Pefloxacin. Proceedings of the 14th International Congress of Chemotherapy, Kyoto 1985. In: J Ishigami (Hrsg.): Recent Advances in Chemotherapy 1985: 1719–1720.
   Google Scholar
• Mulligan M, Ruane P, Johnston L, et al. Ciprofloxacin (C) for Eradication of Oxacillin-Resistant Staphylococcus Aureus (ORSA) Colonization. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy (IGAAC), New Orleans 1986: Abstract 401.
   Google Scholar
• Ragnaud JM, Roche-Bezian MC, Dupon M, Wone C. Management of Peritonitis Related to Chronic Ambulatory Peritoneal Dialysis (CAPD) using two daily Intraperitoneal Injections of 400 mg Pefloxacin. 5th Mediterranean Congress of Chemotherapy, Cairo 1986: Abstract P 232.
   Google Scholar
• Ooishi M, Nagai S, Sakaue F, Oomomo A, Yoneyama K. Clinical Evaluation of Ciprofloxacin in Bacterial Ocular Infections. Proceedings of the 14th International Congress of Chemotherapy, Kyoto 1985. In: J Ishigami (Hrsg): Recent Advances in Chemotherapy 1985: 1699–1700.
   Google Scholar
• Giorgi C, Rio Y, Leroy F, Jurin F, Didion J.Pefloxacin Therapy of Septicemia and Severe Skin Infections in the Burned Patient. Skin Diffusion. 5th Mediterranean Congress of Chemotherapy, Cairo 1986: Abstract 092.
   Google Scholar
• Leal del Rosal R, Leal del Rosal L, Magana JL, Riosvelasco CF. Result of a comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in patients with skin and soft tissue infections. Am J Med (in press).
   Google Scholar
• Perez-Ruvalcaba JA, Quintero-Perez NP, Morales-Reyes JJ, Huitron-Ramirez JA, Rodriguez-Chagollan JJ, Rodriguez-Noriega E. Double-blind comparison of ciprofloxacin (CPX) with cefotaxime (CTX) in the treatment of skin and skin structure infections (SSI). Am J. Med (in press)
   Google Scholar
• Rodriguez-Noriega E, Perez-Ruvalcaba JA, Quintero-Perez NP, Morales-Reyes JJ, Huitron-Ramirez JA, Rodriguez-Chagollan JJ. Double blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections. Am J Med (in press).
   Google Scholar